Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States · Biotechnology, Health Care, Medical
The Barbara Ann Karmanos Cancer Institute is a trailblazer in cancer research and a major contributor to significant strides in new drug and therapy development. It is an NCI-Designated Comprehensive Cancer Center with access to a diverse cancer population, shaping the understanding of cancer and treatment for multiple populations.
Key facts
- Headquarters
- Detroit, Michigan, United States
- Employees
- 1,202
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- karmanos.org
- Company page
Recent activity at Barbara Ann Karmanos Cancer Institute
Leadership
- Boris Pasche, President and CEO
- Stephen Kaurala, Pharmacy Ambulatory Manager
- Stefan C. Grant, Director
Verified email and direct lines for Barbara Ann Karmanos Cancer Institute’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Barbara Ann Karmanos Cancer Institute in the news
- Wayne State University and Barbara Ann Karmanos Cancer Institute researchers establish new Digital Engagement and Cancer Outcomes Center with ACS grant - Division of Research & Innovation - Wayne State University (Apr 22, 2026)
- Karmanos Cancer Institute Welcomes New Associate Center Director for the Cancer Network, Thoracic Medical Oncologist to the Team - McLaren Health Care (Oct 06, 2026)
- Karmanos Cancer Institute Rolls Out New Oncology Clinical Trials App Features - McLaren Health Care (Jul 13, 2026)
- Internationally known clinical and translational researcher joins WSU and Karmanos, co-leads the GI oncology team - Today@Wayne (May 20, 2024)
- Barbara Ann Karmanos Cancer Institute and Wayne State University name Boris C. Pasche, M.D., Ph.D., FACP, President and Chief Executive Officer - PR Newswire (Aug 07, 2023)
- Karmanos Cancer Institute Expands Targeted Radiopharmaceutical Therapies to Additional Cancer Centers - McLaren Health Care (Apr 21, 2026)
- Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research - Business Wire (Jan 05, 2022)
- Comedian Michael Kosta Headlines Karmanos Comedy Champions - McLaren Health Care (Apr 13, 2026)
Companies similar to Barbara Ann Karmanos Cancer Institute
- MTF Biologics · Biotechnology, Health Care, Medical, Non Profit
- CancerCare Manitoba · Biotechnology, Health Care, Medical, Non Profit
- Morehouse School of Medicine · Biotechnology, Health Care, Medical, Non Profit
- ALIMA · Biotechnology, Health Care, Medical, Non Profit
- Susan G. Komen · Biotechnology, Health Care, Medical, Non Profit
About Barbara Ann Karmanos Cancer Institute: questions and answers
What does Barbara Ann Karmanos Cancer Institute do?
The Barbara Ann Karmanos Cancer Institute is a trailblazer in cancer research and a major contributor to significant strides in new drug and therapy development. It is an NCI-Designated Comprehensive Cancer Center with access to a diverse cancer population, shaping the understanding of cancer and treatment for multiple populations.
Where is Barbara Ann Karmanos Cancer Institute headquartered?
Barbara Ann Karmanos Cancer Institute is headquartered in Detroit, Michigan, United States.
How many employees does Barbara Ann Karmanos Cancer Institute have?
Barbara Ann Karmanos Cancer Institute has about 1,202 employees.
Who leads Barbara Ann Karmanos Cancer Institute?
Boris Pasche is a President and CEO at Barbara Ann Karmanos Cancer Institute.
What is the latest news on Barbara Ann Karmanos Cancer Institute?
On Oct 06, 2026, Karmanos Cancer Institute Appoints Dr. Stefan Grant as Associate Center Director
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy